KRTL BioTech

Activist Politan Capital engages with Azenta. Here’s how the firm may boost shareholder value

Activist Politan Capital engages with Azenta. Here’s how the firm may boost shareholder value

Azenta is sitting on a pile of cash, and shareholders will want to know the company's plans for the money.